Agram Pharmaceuticals Llp - Company Profile

It is a pharma limited liability partnership based in Delhi, Delhi, India, established in 2015.
2015 Delhi, Delhi, India Active
Last Updated:
Access Report
About Agram Pharmaceuticals Llp

Agram Pharmaceuticals Llp, a active limited liability partnership, was established on 11 June 2015 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAE-1514. Registered under ROC Roc Delhi. It has total obligation of contribution of ₹2.10 M.

Its leadership includes Rajendra Kumar Verma (Designated Partner), Chandra Kala Verma (Designated Partner). It holds ₹7.81 Cr open charges and ₹5.30 M settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at Unit No.1209, D-Mall, Plot No. A1, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAE-1514

  • Incorporation Date

    11 June 2015

  • Total Obligation of Contribution

    ₹2.10 M

  • ROC Code

    Roc Delhi

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 2.10 M
  • Company Age 11 Year, 24 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 7.81 Cr
  • Satisfied Charges ₹ 5.30 M
Company report

Agram Pharmaceuticals Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Agram Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Agram Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Rajendra Kumar Verma Designated Partner 11 Jun 2015 Current
Chandra Kala Verma Designated Partner 11 Jun 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Agram Pharmaceuticals Llp.

Enhance accessibility to Agram Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Agram Pharmaceuticals Llp revenue growth over time
Agram Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Agram Pharmaceuticals Llp?

Unlock access to Agram Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹78,084,000.00

Satisfied Charges

₹5,300,000.00

Charges Breakdown by Lending Institutions
  • United Bank Of India : 5.81 Cr
  • Bank Of Baroda : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
18 Aug 2025 United Bank Of India ₹5.81 Cr Open
30 Jan 2025 Bank Of Baroda ₹2.00 Cr Open
05 May 2020 State Bank Of India ₹5.30 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Agram Pharmaceuticals Llp?

Unlock and access historical data on people associated with Agram Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Agram Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agram Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Agram Pharmaceuticals Llp
Recent Activity within the Organization
  • Charges

    Progress on A charge with United Bank Of India amounted to Rs. 58.08 M with Charge ID 101147763 was registered on 18 Aug 2025. was documented.

  • Annual General Meeting

    The activity Agram Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Agram Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    The activity A charge with Bank Of Baroda amounted to Rs. 20.00 M with Charge ID 101050186 was registered on 30 Jan 2025. was completed.

  • Charges

    The activity A charge registered on 05 May 2020 via Charge ID 100340854 with State Bank Of India was fully satisfied on 14 May 2024. was completed.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 5.30 M with Charge ID 100340854 was registered on 05 May 2020. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Agram Pharmaceuticals Llp?

The LLPIN of Agram Pharmaceuticals Llp is AAE-1514.

Where is Agram Pharmaceuticals Llp headquartered?

Agram Pharmaceuticals Llp is headquartered at Unit No.1209, D-Mall, Plot No. A1, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.

When was Agram Pharmaceuticals Llp incorporated?

Agram Pharmaceuticals Llp was incorporated on 11 June 2015.

Who are the current directors of Agram Pharmaceuticals Llp?

The current directors of Agram Pharmaceuticals Llp are

What is the primary industry of Agram Pharmaceuticals Llp?

The primary industry of Agram Pharmaceuticals Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available